Breaking News Instant updates and real-time market news.

ATHM

Autohome

$104.35

1.72 (1.68%)

, BABA

Alibaba

$178.30

-1.25 (-0.70%)

09:20
04/04/19
04/04
09:20
04/04/19
09:20

CLSA China internet analyst to hold an analyst/industry conference call

China Internet Analyst discusses the industry on an Analyst/Industry conference call to be held on April 4 at 10 am.

ATHM

Autohome

$104.35

1.72 (1.68%)

BABA

Alibaba

$178.30

-1.25 (-0.70%)

BIDU

Baidu

$174.86

4.34 (2.55%)

BZUN

Baozun

$44.26

2.26 (5.38%)

PDD

Pinduoduo

$23.53

-0.92 (-3.76%)

IQ

iQIYI

$24.04

-0.26 (-1.07%)

  • 05

    Apr

ATHM Autohome
$104.35

1.72 (1.68%)

12/03/18
12/03/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Autohome (ATHM) initiated with an Outperform at Macquarie. 2. Livent (LTHM) initiated with a Buy at HSBC while Albemarle (ALB) was initiated with a Hold. 3. Career Education (CECO) initiated with an Outperform at Barrington. 4. NRC Group (NRCG) initiated with a Buy at Stifel. 5. Waitr Holdings (WTRH) initiated with a Buy at Craig-Hallum. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/28/19
JPMS
01/28/19
DOWNGRADE
Target $58
JPMS
Underweight
Autohome downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Binbin Ding downgraded Autohome to Underweight and cut his price target for the shares to $58 from $68. The analyst expects the company to see weakened pricing power amid a "challenging" market environment.
02/27/19
FBCO
02/27/19
DOWNGRADE
FBCO
Neutral
Autohome downgraded to Neutral from Outperform at Credit Suisse
01/28/19
01/28/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Autohome (ATHM) downgraded to Underweight from Neutral at JPMorgan with analyst Binbin Ding saying he expects the company to see weakened pricing power amid a "challenging" market environment. 2. Vale (VALE) downgraded to Hold from Buy at HSBC and Jefferies, to Neutral from Outperform at Macquarie, and to Market Perform from Outperform at BMO Capital. 3. Amgen (AMGN) downgraded to In Line from Outperform at Evercore ISI with analyst Umer Raffat citing increased biosimilar competition and an imminent court decision on Enbrel patents with Sandoz. 4. Dynagas LNG (DLNG) downgraded to Neutral from Buy at B. Riley FBR with analyst Liam Burke saying the company "significantly" reduced its cash distribution in order to strengthen its balance sheet. 5. SunTrust (STI) and U.S. Bancorp (USB) were downgraded to Neutral from Outperform at Baird. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BABA Alibaba
$178.30

-1.25 (-0.70%)

04/04/19
JPMS
04/04/19
DOWNGRADE
Target $78
JPMS
Neutral
JPMorgan downgrades Altaba to Neutral ahead of dissolution
JPMorgan analyst Douglas Anmuth downgraded Altaba (AABA) to Neutral from Overweight and lowered his price target for the shares to $78 from $84. Altaba yesterday announced its board approved plans for a voluntary liquidation and dissolution, with total distributions paid expected between $76.62 and $79.22 per share, which represents ~5-9% upside from current levels, Anmuth tells investors in a research note. The analyst says this is not the tax-efficient outcome he had hoped for. He believes Altaba's ability to execute the most efficient transaction ultimately depended on Alibaba's (BABA) interest and willingness to participate, and "it was clear Alibaba has not shown an interest in repurchasing its shares." His Neutral rating reflects his expectation for a Q4 dissolution.
04/03/19
JEFF
04/03/19
NO CHANGE
Target $200
JEFF
Buy
Altaba exit may weigh on near-term Alibaba sentiment, says Jefferies
Altaba's (AABA) liquidation plan, with includes exiting its 11% stake in Alibaba Group (BABA), may weigh on near-term sentiment for Alibaba's share price, Jefferies analyst Karen Chan tells investors in a researcher note. If its plan is approved by shareholders, Altaba would sell its remaining shares in Alibaba through open market transactions and/or private dispositions, resulting in an expected liquidation distribution of approximately $39.8B-$41.1B in Q4, Chan writes. Altaba intends to sell no more than 50% of its Alibaba shares prior to receiving stockholder approval, the analyst adds. Chan, however, continues to like Alibaba's "resilience and expansion into the Chinese online consumption pocket with high-margin feed monetization lever remaining in place." She believes the company's fundamentals remain intact and keeps a Buy rating on the name with a $200 price target. Alibaba Group is down 2%, or $3.24, to $178.47 in early trading while Altaba is down 1% to $72.98.
04/01/19
BOFA
04/01/19
NO CHANGE
Target $215
BOFA
Buy
Alibaba's Alipay evolving into 'super-app,' says BofA/Merrill
BofA/Merrill analyst Eddie Leung believes Ant Financial's Alipay app will emerge into a "large mobile platform." He sees Alipay "serving the needs in everyday life of its users and offering bigger opportunities to cooperate with the other business units" under Alibaba (BABA). The cooperation with the Alibaba business units should bring mutual benefits and allow Alipay to evolve into a "super-app," Leung tells investors in a research note. The analyst has a Buy rating on Alibaba with a $215 price target.
03/28/19
BARD
03/28/19
NO CHANGE
BARD
Alibaba price target raised to $195 from $178 at Baird
Baird analyst Colin Sebastian maintained his Outperform rating on Alibaba, and increased his price target on shares to $195 from $178. The analyst called Alibaba-subsidiary Lazada an "under-appreciated asset with a well-developed growth strategy geared to the inflecting Southeast Asia e-commerce market," and believes revenue diversification for the company outside China will be a future stock catalyst.
BIDU Baidu
$174.86

4.34 (2.55%)

02/25/19
SUSQ
02/25/19
NO CHANGE
Target $220
SUSQ
Positive
Baidu second half setting up well, says Susquehanna
Susquehanna analyst Shyam Patil said Baidu is investing for growth and looks to be set up well for the second half of 2019. The analyst said the company showed resiliency with the core performance of its advertising offering and execution on emerging growth areas despite the regulatory and macro uncertainty which continues to weigh on the overall picture. He sees the company as the dominant player in China's search market, a key player in the emerging feeds market, owner of one of the top video assets in the country, and a market leader in AI applications. Patil has a $220 price target on Baidu shares.
02/22/19
BNCH
02/22/19
NO CHANGE
Target $245
BNCH
Buy
Baidu price target lowered to $245 from $260 at Benchmark
Benchmark analyst Fawne Jiang lowered her price target on Baidu shares to $245 from $260 following the company's mixed Q4 results, noting that management expects to aggressively ramp up investments in marketing promotions for mobile app downloads and content expansion in FY19. Baidu's margins could be under pressure in the coming quarters with 2019 "shaping up to be an investment year," said Jiang, who remains constructive on Baidu's AI focused strategy over the longer term. She keeps a Buy rating on Baidu shares.
01/28/19
OPCO
01/28/19
NO CHANGE
Target $210
OPCO
Outperform
Baidu price target lowered to $210 from $230 at Oppenheimer
Oppenheimer analyst Jason Helfstein lowered his price target for Baidu (BIDU) to $210 from $230 on slower revenue, higher investments in 2019, his firm's recently lowered Ctrip (CTRP) price target and recent downward movement of iQIYI (IQ) shares. The analyst now expects Baidu to continue investing in key areas, such as content and sales and marketing in 2019, regardless of softer advertising industry trends. Additionally, he expects the recently announced CCTV CNY gala sponsorship to have a one-off negative impact on Q1 margins due to higher marketing dollars, but beneficial to user acquisition. Helfstein reiterates an Outperform rating on Baidu's shares.
01/25/19
01/25/19
UPGRADE

Positive
Follow-up: Baidu upgraded to Positive following checks at OTR Global
As previously reported, OTR Global upgraded Baidu to Positive from Mixed. The firm's Q4 industry checks indicate advertising growth on Baidu China improved partially driven by demand for sophisticated targeting resources and increased adoption of Newsfeed advertising.
BZUN Baozun
$44.26

2.26 (5.38%)

10/11/18
THCP
10/11/18
NO CHANGE
THCP
Baozun likely to be conservative with guidance, says TH Data Capital
TH Data Capital analyst Tian Hou believes Baozun added 10 GMV partners and 8 brand partners in Q3 and expects the company's net revenue growth to be in line with the consensus view and largely inline with the mid-point of company view. Given the slower pace of Chinese economic growth, Hou believes Baozun, along with many other Chinese companies, will take a conservative approach toward its guidance, he tells investors.
10/11/18
LYON
10/11/18
UPGRADE
LYON
Buy
Baozun upgraded to Buy from Outperform at CLSA
CLSA analyst Man Ho Lam upgraded Baozun to Buy ahead of Q3 results citing the recent pullback in shares.
PDD Pinduoduo
$23.53

-0.92 (-3.76%)

01/16/19
MSCO
01/16/19
INITIATION
Target $29
MSCO
Overweight
Pinduoduo initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Grace Chen initiated Pinduoduo with an Overweight rating and $29 price target, citing her view that the company is "best positioned" to benefit from growth in e-commerce in low-tier cities in China.
03/06/19
UBSW
03/06/19
INITIATION
UBSW
Buy
Pinduoduo initiated with a Buy at UBS
11/15/18
OTRG
11/15/18
NO CHANGE
OTRG
Pinduoduo sales meeting or exceeding expectations, says OTR Global
OTR Global's checks with Pinduoduo vendors indicates aggressive marketing and increased brand awareness have resulted in increased users and vendors meeting or exceeding expectations.
03/06/19
03/06/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Voyager Therapeutics (VYGR) initiated with an Overweight at Cantor Fitzgerald. 2. L.B. Foster (FSTR) initiated with a Buy at B. Riley FBR. 3. Raymond James (RJF) initiated with a Buy at Argus. 4. Chegg (CHGG) initiated with a Buy at Berenberg. 5. Pinduoduo (PDD) initiated with a Buy at UBS. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
IQ iQIYI
$24.04

-0.26 (-1.07%)

02/22/19
NWST
02/22/19
UPGRADE
NWST
Buy
iQIYI upgraded to Buy from Neutral at New Street
01/14/19
OTRG
01/14/19
DOWNGRADE
OTRG
Mixed
iQIYI downgraded to Mixed from Positive at OTR Global
03/15/19
TIGR
03/15/19
INITIATION
TIGR
Buy
iQIYI initiated with a Buy at Tigress Financial
Tigress Financial analyst Aaron Ju initiated coverage earlier on iQIYI with a Buy rating, citing what he views as a leading position in the online streaming video sector and its ability to create high quality, original online content. Additionally, iQIYI's ongoing investment in technology should continue to drive its market share penetration, the analyst contends.

TODAY'S FREE FLY STORIES

OKE

Oneok

$69.13

-0.59 (-0.85%)

16:17
04/18/19
04/18
16:17
04/18/19
16:17
Hot Stocks
Oneok increases quarterly dividend 9% to 86.5c per share »

Oneok increased its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
04/18/19
04/18
16:17
04/18/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
04/18/19
04/18
16:16
04/18/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEP

Holly Energy Partners

$28.23

0.51 (1.84%)

16:16
04/18/19
04/18
16:16
04/18/19
16:16
Hot Stocks
Holly Energy Partners raises dividend to 67c per unit from 66.75c »

The distribution will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

HES

Hess Corp.

$65.87

-0.05 (-0.08%)

16:15
04/18/19
04/18
16:15
04/18/19
16:15
Hot Stocks
Hess Corp. announces 13th discovery offshore Guyana »

Hess Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 22

    May

  • 29

    May

16:15
04/18/19
04/18
16:15
04/18/19
16:15
General news
Breaking General news story  »

Week of 4/17 Fed Balance…

16:15
04/18/19
04/18
16:15
04/18/19
16:15
General news
Breaking General news story  »

Week of 4/8 Money Supply…

DTRM

Determine

$0.00

(0.00%)

16:13
04/18/19
04/18
16:13
04/18/19
16:13
Hot Stocks
Determine announces winding up, liquidation, and dissolution »

Determine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRTA

Prothena

$10.67

-0.08 (-0.74%)

16:12
04/18/19
04/18
16:12
04/18/19
16:12
Hot Stocks
Prothena will explore potential business development opportunities for NEOD001 »

Prothena reports results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

FFIN

First Financial

$60.25

-0.32 (-0.53%)

16:11
04/18/19
04/18
16:11
04/18/19
16:11
Earnings
First Financial reports Q1 EPS 56c, consensus 56c »

Reports Q1 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

INDB

Independent Bank

$84.23

-0.98 (-1.15%)

16:11
04/18/19
04/18
16:11
04/18/19
16:11
Earnings
Independent Bank reports Q1 EPS $1.30, consensus $1.29 »

Reports Q1 NII $82.5M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 13

    May

  • 16

    May

EXPO

Exponent

$56.31

0.15 (0.27%)

16:11
04/18/19
04/18
16:11
04/18/19
16:11
Earnings
Exponent reports Q1 EPS 42c, consensus 36c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

SRCE

1st Source

$46.04

-0.68 (-1.46%)

16:11
04/18/19
04/18
16:11
04/18/19
16:11
Earnings
1st Source reports Q1 EPS 86c, consensus 85c »

According to Christopher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

AMNB

American National Bankshares

$35.04

-0.25 (-0.71%)

16:10
04/18/19
04/18
16:10
04/18/19
16:10
Earnings
Breaking Earnings news story on American National Bankshares »

American National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$60.71

0.56 (0.93%)

16:10
04/18/19
04/18
16:10
04/18/19
16:10
Hot Stocks
Lumentum sees revenue from datacom transceivers down $20M-$25M in Q4 »

Lumentum announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 28

    May

TRNO

Terreno Realty

$43.11

0.44 (1.03%)

16:09
04/18/19
04/18
16:09
04/18/19
16:09
Hot Stocks
Terreno Realty executes 192K sqm lease in Florida »

Terreno Realty announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 07

    May

  • 08

    May

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

, AKRX

Akorn

$2.77

-0.16 (-5.46%)

16:09
04/18/19
04/18
16:09
04/18/19
16:09
Hot Stocks
Innovus announces FDA approval for Akorn's ANDA for FlutiCare »

Innovus Pharmaceuticals…

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

AKRX

Akorn

$2.77

-0.16 (-5.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 07

    May

ISRG

Intuitive Surgical

$530.12

5.37 (1.02%)

16:09
04/18/19
04/18
16:09
04/18/19
16:09
Earnings
Intuitive Surgical says worldwide da Vinci procedures grew 18% »

Intuitive Surgical said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 25

    Apr

  • 03

    May

ISRG

Intuitive Surgical

$529.84

5.09 (0.97%)

16:07
04/18/19
04/18
16:07
04/18/19
16:07
Earnings
Intuitive Surgical reports Q1 EPS $2.61, consensus $2.70 »

Reports Q1 revenue $974M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 25

    Apr

  • 03

    May

UIHC

United Insurance

$16.45

0.28 (1.73%)

16:06
04/18/19
04/18
16:06
04/18/19
16:06
Hot Stocks
United Insurance estimates Q1 catastrophe losses of roughly $18M pre-tax »

United Insurance Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ADAP

Adaptimmune

$4.08

-0.23 (-5.34%)

16:05
04/18/19
04/18
16:05
04/18/19
16:05
Hot Stocks
Adaptimmune announces presentation of allogeneic SPEAR T-cell program at ASGCT »

Adaptimmune announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$145.34

-0.56 (-0.38%)

16:05
04/18/19
04/18
16:05
04/18/19
16:05
Hot Stocks
D.E. Shaw reports 5.0% passive stake in Wayfair »

D.E. Shaw disclosed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

PBCT

People's United

$17.12

-0.215 (-1.24%)

16:05
04/18/19
04/18
16:05
04/18/19
16:05
Hot Stocks
People's United raises annual dividend to 71c per share »

The company's Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 16

    May

NNBR

NN, Inc.

$9.71

0.03 (0.31%)

16:05
04/18/19
04/18
16:05
04/18/19
16:05
Hot Stocks
NN, Inc.closing Tennessee shared service center »

NN, Inc. will close its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

PBCT

People's United

$17.13

-0.2 (-1.15%)

16:04
04/18/19
04/18
16:04
04/18/19
16:04
Hot Stocks
People's United reports Q1 net interest margin 3.2% »

Reports Q1 efficiency…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 16

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.